Preparation time and usability assessment of commercially available freeze-dried respiratory syncytial virus vaccine presentations
Compared with the V/V, the AOV was faster, preferred by participants, and reported to have more usability benefits. Findings suggest that AOV will be well accepted by HCPs.
Authors
- B. Conrad
- Sarah Weiser (ORCID: https://orcid.org/0000-0002-7899-678X)
- Erica Chilson (ORCID: https://orcid.org/0000-0002-4417-3398)
- Michael Bruchsaler
- Simon Moss (ORCID: https://orcid.org/0000-0001-5378-7773)
- Robyn Moucka
Institutions
- Pfizer (United States) (US)
Publication Details
- Journal
- Expert Review of Vaccines
- Published
- 2025-09-16
- DOI
- https://doi.org/10.1080/14760584.2025.2559672
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 0.00